Corticotropin releasing factor: A key role in the neurobiology of addiction

Frontiers in Neuroendocrinology

Volumn 35, Issue 2, 2014, Pages 234-244

  Zorrilla, Eric P ^a   Logrip, Marian L ^a   Koob, George F ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Acute or protracted withdrawal or abstinence; Alcohol or ethanol; Anxiety disorder; Corticotropin releasing factor or hormone receptor antagonist; CRF or CRH or urocortin 1 or urocortin 2 or urocortin 3; Drug addiction or alcoholism or alcohol dependence or alcohol use disorder or binge drinking; Major depression; Stress induced relapse or reinstatement or craving; Treatment or clinical trial

Indexed keywords

ANTISAUVAGINE 30; ASTRESSIN 2 B; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR ANTAGONIST; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; CORTICOTROPIN RELEASING FACTOR RECEPTOR 2; PEXACERFONT; UNCLASSIFIED DRUG; UROCORTIN I; VERUCERFONT;

ADDICTION; ALCOHOL CONSUMPTION; ALCOHOLISM; ANXIETY DISORDER; CELLULAR STRESS RESPONSE; CENTRAL NUCLEUS (AMYGDALA); DRUG DEPENDENCE; DRUG SEEKING BEHAVIOR; FRONTAL CORTEX; GENETIC HETEROGENEITY; HUMAN; NEUROBIOLOGY; NONHUMAN; OPIATE ADDICTION; PREFRONTAL CORTEX; PRIORITY JOURNAL; REVIEW; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; ANIMAL; BRAIN; MENTAL STRESS; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGICAL STRESS; SUBSTANCE-RELATED DISORDERS;

ANIMALS; BEHAVIOR, ADDICTIVE; BRAIN; CORTICOTROPIN-RELEASING HORMONE; HUMANS; STRESS, PHYSIOLOGICAL; STRESS, PSYCHOLOGICAL; SUBSTANCE-RELATED DISORDERS;

EID: 84896138011     PISSN: 00913022     EISSN: 10956808     Source Type: Journal    
DOI: 10.1016/j.yfrne.2014.01.001     Document Type: Review

References (198)

1. Alling C., Balldin J., Bokstrom K., Gottfries C.G., Karlsson I., Langstrom G. Studies on duration of a late recovery period after chronic abuse of ethanol. A cross-sectional study of biochemical and psychiatric indicators. Acta Psychiatr. Scand. 1982, 66:384-397.
2. Anacker A.M., Loftis J.M., Kaur S., Ryabinin A.E. Prairie voles as a novel model of socially facilitated excessive drinking. Addict. Biol. 2011, 16:92-107.
3. Annis H.M., Sklar S.M., Moser A.E. Gender in relation to relapse crisis situations, coping, and outcome among treated alcoholics. Addict. Behav. 1998, 23:127-131.
4. Ayanwuyi L.O., Carvajal F., Lerma-Cabrera J.M., Domi E., Bjork K., Ubaldi M., Heilig M., Roberto M., Ciccocioppo R., Cippitelli A. Role of a genetic polymorphism in the corticotropin-releasing factor receptor 1 gene in alcohol drinking and seeking behaviors of Marchigian Sardinian alcohol-preferring rats. Front. Psychiatry 2013, 4:23.
5. Aydin C., Oztan O., Isgor C. Vulnerability to nicotine abstinence-related social anxiety-like behavior: molecular correlates in neuropeptide Y, Y2 receptor and corticotropin releasing factor. Neurosci. Lett. 2011, 490:220-225.
6. Bachtell R.K., Wang Y.M., Freeman P., Risinger F.O., Ryabinin A.E. Alcohol drinking produces brain region-selective changes in expression of inducible transcription factors. Brain Res. 1999, 847:157-165.
7. Bachtell R.K., Tsivkovskaia N.O., Ryabinin A.E. Strain differences in urocortin expression in the Edinger-Westphal nucleus and its relation to alcohol-induced hypothermia. Neuroscience 2002, 113:421-434.
8. Bachtell R.K., Weitemier A.Z., Galvan-Rosas A., Tsivkovskaia N.O., Risinger F.O., Phillips T.J., Grahame N.J., Ryabinin A.E. The Edinger-Westphal-lateral septum urocortin pathway and its relationship to alcohol consumption. J. Neurosci. 2003, 23:2477-2487.
9. Bachtell R.K., Weitemier A.Z., Ryabinin A.E. Lesions of the Edinger-Westphal nucleus in C57BL/6J mice disrupt ethanol-induced hypothermia and ethanol consumption. Eur. J. Neurosci. 2004, 20:1613-1623.
10. Bale T.L., Vale W.W. CRF and CRF receptors: role in stress responsivity and other behaviors. Annu. Rev. Pharmacol. Toxicol. 2004, 44:525-557.
11. Barr C.S., Dvoskin R.L., Gupte M., Sommer W., Sun H., Schwandt M.L., Lindell S.G., Kasckow J.W., Suomi S.J., Goldman D., Higley J.D., Heilig M. Functional CRH variation increases stress-induced alcohol consumption in primates. Proc. Natl. Acad. Sci. USA 2009, 106:14593-14598.
12. Basso A.M., Spina M., Rivier J., Vale W., Koob G.F. Corticotropin-releasing factor antagonist attenuates the "anxiogenic-like" effect in the defensive burying paradigm but not in the elevated plus-maze following chronic cocaine in rats. Psychopharmacology (Berlin) 1999, 145:21-30.
13. Behan D.P., Potter E., Lewis K.A., Jenkins N.A., Copeland N., Lowry P.J., Vale W.W. Cloning and structure of the human corticotrophin releasing factor-binding protein gene (CRHBP). Genomics 1993, 16:63-68.
14. Behan D.P., De Souza E.B., Lowry P.J., Potter E., Sawchenko P., Vale W.W. Corticotropin releasing factor (CRF) binding protein: a novel regulator of CRF and related peptides. Front. Neuroendocrinol. 1995, 16:362-382.
15. Blacktop J.M., Seubert C., Baker D.A., Ferda N., Lee G., Graf E.N., Mantsch J.R. Augmented cocaine seeking in response to stress or CRF delivered into the ventral tegmental area following long-access self-administration is mediated by CRF receptor type 1 but not CRF receptor type 2. J. Neurosci. 2011, 31:11396-11403.
16. Blomeyer D., Treutlein J., Esser G., Schmidt M.H., Schumann G., Laucht M. Interaction between CRHR1 gene and stressful life events predicts adolescent heavy alcohol use. Biol. Psychiatry 2008, 63:146-151.
17. Bossert J.M., Marchant N.J., Calu D.J., Shaham Y. The reinstatement model of drug relapse: recent neurobiological findings, emerging research topics, and translational research. Psychopharmacology (Berlin) 2013, 229:453-476.
18. Boyson C.O., Miguel T.T., Quadros I.M., Debold J.F., Miczek K.A. Prevention of social stress-escalated cocaine self-administration by CRF-R1 antagonist in the rat VTA. Psychopharmacology (Berlin) 2011, 218:257-269.
19. Breese G.R., Overstreet D.H., Knapp D.J. Conceptual framework for the etiology of alcoholism: a "kindling"/stress hypothesis. Psychopharmacology (Berlin) 2005, 178:367-380.
20. Breese G.R., Overstreet D.H., Knapp D.J., Navarro M. Prior multiple ethanol withdrawals enhance stress-induced anxiety-like behavior: inhibition by CRF1- and benzodiazepine-receptor antagonists and a 5-HT1a-receptor agonist. Neuropsychopharmacology 2005, 30:1662-1669.
21. Breese G.R., Sinha R., Heilig M. Chronic alcohol neuroadaptation and stress contribute to susceptibility for alcohol craving and relapse. Pharmacol. Ther. 2011, 129:149-171.
22. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: II. Clinical studies. Synapse 1996, 23:39-51.
23. Briand L.A., Flagel S.B., Garcia-Fuster M.J., Watson S.J., Akil H., Sarter M., Robinson T.E. Persistent alterations in cognitive function and prefrontal dopamine D2 receptors following extended, but not limited, access to self-administered cocaine. Neuropsychopharmacology 2008, 33:2969-2980.
24. Briand L.A., Gross J.P., Robinson T.E. Impaired object recognition following prolonged withdrawal from extended-access cocaine self-administration. Neuroscience 2008, 155:1-6.
25. Brown Z.J., Kupferschmidt D.A., Erb S. Reinstatement of cocaine seeking in rats by the pharmacological stressors, corticotropin-releasing factor and yohimbine: role for D1/5 dopamine receptors. Psychopharmacology (Berlin) 2012, 224:431-440.
26. Bruijnzeel A.W., Zislis G., Wilson C., Gold M.S. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats. Neuropsychopharmacology 2007, 32:955-963.
27. Bruijnzeel A.W., Prado M., Isaac S. Corticotropin-releasing factor-1 receptor activation mediates nicotine withdrawal-induced deficit in brain reward function and stress-induced relapse. Biol. Psychiatry 2009, 66:110-117.
28. Bruijnzeel A.W., Small E., Pasek T.M., Yamada H. Corticotropin-releasing factor mediates the dysphoria-like state associated with alcohol withdrawal in rats. Behav. Brain Res. 2010, 210:288-291.
29. Bruijnzeel A.W., Ford J., Rogers J.A., Scheick S., Ji Y., Bishnoi M., Alexander J.C. Blockade of CRF1 receptors in the central nucleus of the amygdala attenuates the dysphoria associated with nicotine withdrawal in rats. Pharmacol. Biochem. Behav. 2012, 101:62-68.
30. Buffalari D.M., Baldwin C.K., Feltenstein M.W., See R.E. Corticotrophin releasing factor (CRF) induced reinstatement of cocaine seeking in male and female rats. Physiol. Behav. 2012, 105:209-214.
31. Chalmers D.T., Lovenberg T.W., De Souza E.B. Localization of novel corticotropin-releasing factor receptor (CRF2) mRNA expression to specific subcortical nuclei in rat brain: comparison with CRF1 receptor mRNA expression. J. Neurosci. 1995, 15:6340-6350.
32. Chen A.C., Manz N., Tang Y., Rangaswamy M., Almasy L., Kuperman S., Nurnberger J., O'connor S.J., Edenberg H.J., Schuckit M.A., Tischfield J., Foroud T., Bierut L.J., Rohrbaugh J., Rice J.P., Goate A., Hesselbrock V., Porjesz B. Single-nucleotide polymorphisms in corticotropin releasing hormone receptor 1 gene (CRHR1) are associated with quantitative trait of event-related potential and alcohol dependence. Alcohol. Clin. Exp. Res. 2010, 34:988-996.
33. Childress A.R., Ehrman R., Mclellan A.T., Macrae J., Natale M., O'brien C.P. Can induced moods trigger drug-related responses in opiate abuse patients?. J. Subst. Abuse Treat. 1994, 11:17-23.
34. Chu K., Koob G.F., Cole M., Zorrilla E.P., Roberts A.J. Dependence-induced increases in ethanol self-administration in mice are blocked by the CRF1 receptor antagonist antalarmin and by CRF1 receptor knockout. Pharmacol. Biochem. Behav. 2007, 86:813-821.
35. Ciccocioppo R., Economidou D., Cippitelli A., Cucculelli M., Ubaldi M., Soverchia L., Lourdusamy A., Massi M. Genetically selected Marchigian Sardinian alcohol-preferring (msP) rats: an animal model to study the neurobiology of alcoholism. Addict. Biol. 2006, 11:339-355.
36. Cippitelli A., Damadzic R., Singley E., Thorsell A., Ciccocioppo R., Eskay R.L., Heilig M. Pharmacological blockade of corticotropin-releasing hormone receptor 1 (CRH1R) reduces voluntary consumption of high alcohol concentrations in non-dependent Wistar rats. Pharmacol. Biochem. Behav. 2012, 100:522-529.
37. Contarino A., Papaleo F. The corticotropin-releasing factor receptor-1 pathway mediates the negative affective states of opiate withdrawal. Proc. Natl. Acad. Sci. USA 2005, 102:18649-18654.
38. Cooney N.L., Litt M.D., Morse P.A., Bauer L.O., Gaupp L. Alcohol cue reactivity, negative-mood reactivity, and relapse in treated alcoholic men. J. Abnorm. Psychol. 1997, 106:243-250.
39. Cottone P., Sabino V., Roberto M., Bajo M., Pockros L., Frihauf J.B., Fekete E.M., Steardo L., Rice K.C., Grigoriadis D.E., Conti B., Koob G.F., Zorrilla E.P. CRF system recruitment mediates dark side of compulsive eating. Proc. Natl. Acad. Sci. USA 2009, 106:20016-20020.
40. Enoch M.A., White K.V., Harris C.R., Robin R.W., Ross J., Rohrbaugh J.W., Goldman D. Association of low-voltage alpha EEG with a subtype of alcohol use disorders. Alcohol. Clin. Exp. Res. 1999, 23:1312-1319.
41. Enoch M.A., Shen P.H., Ducci F., Yuan Q., Liu J., White K.V., Albaugh B., Hodgkinson C.A., Goldman D. Common genetic origins for EEG, alcoholism and anxiety: the role of CRH-BP. PLoS ONE 2008, 3:e3620.
42. Erb S., Shaham Y., Stewart J. The role of corticotropin-releasing factor and corticosterone in stress- and cocaine-induced relapse to cocaine seeking in rats. J. Neurosci. 1998, 18:5529-5536.
43. Fekete E.M., Zorrilla E.P. Physiology, pharmacology, and therapeutic relevance of urocortins in mammals: ancient CRF paralogs. Front. Neuroendocrinol. 2007, 28:1-27.
44. Fekete E.M., Inoue K., Zhao Y., Rivier J.E., Vale W.W., Szucs A., Koob G.F., Zorrilla E.P. Delayed satiety-like actions and altered feeding microstructure by a selective type 2 corticotropin-releasing factor agonist in rats: intra-hypothalamic urocortin 3 administration reduces food intake by prolonging the post-meal interval. Neuropsychopharmacology 2007, 32:1052-1068.
45. Feltenstein M.W., Ghee S.M., See R.E. Nicotine self-administration and reinstatement of nicotine-seeking in male and female rats. Drug Alcohol Depend. 2012, 121:240-246.
46. Fonareva I., Spangler E., Cannella N., Sabino V., Cottone P., Ciccocioppo R., Zorrilla E.P., Ryabinin A.E. Increased perioculomotor urocortin 1 immunoreactivity in genetically selected alcohol preferring rats. Alcohol. Clin. Exp. Res. 2009, 33:1956-1965.
47. Francesconi W., Berton F., Repunte-Canonigo V., Hagihara K., Thurbon D., Lekic D., Specio S.E., Greenwell T.N., Chen S.A., Rice K.C., Richardson H.N., O'dell L.E., Zorrilla E.P., Morales M., Koob G.F., Sanna P.P. Protracted withdrawal from alcohol and drugs of abuse impairs long-term potentiation of intrinsic excitability in the juxtacapsular bed nucleus of the stria terminalis. J. Neurosci. 2009, 29:5389-5401.
48. Funk C.K., Koob G.F. A CRF(2) agonist administered into the central nucleus of the amygdala decreases ethanol self-administration in ethanol-dependent rats. Brain Res. 2007, 1155:172-178.
49. Funk C.K., O'dell L.E., Crawford E.F., Koob G.F. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats. J. Neurosci. 2006, 26:11324-11332.
50. Funk C.K., Zorrilla E.P., Lee M.J., Rice K.C., Koob G.F. Corticotropin-releasing factor 1 antagonists selectively reduce ethanol self-administration in ethanol-dependent rats. Biol. Psychiatry 2007, 61:78-86.
51. Garcia-Carmona J.A., Almela P., Baroja-Mazo A., Milanes M.V., Laorden M.L. Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal. Psychopharmacology (Berlin) 2012, 220:379-393.
52. Gehlert D.R., Cippitelli A., Thorsell A., Le A.D., Hipskind P.A., Hamdouchi C., Lu J., Hembre E.J., Cramer J., Song M., Mckinzie D., Morin M., Ciccocioppo R., Heilig M. 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2,6-dimethyl-imidazo [1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism. J. Neurosci. 2007, 27:2718-2726.
53. George O., Ghozland S., Azar M.R., Cottone P., Zorrilla E.P., Parsons L.H., O'dell L.E., Richardson H.N., Koob G.F. CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats. Proc. Natl. Acad. Sci. USA 2007, 104:17198-17203.
54. George O., Mandyam C.D., Wee S., Koob G.F. Extended access to cocaine self-administration produces long-lasting prefrontal cortex-dependent working memory impairments. Neuropsychopharmacology 2008, 33:2474-2482.
55. George O., Sanders C., Freiling J., Grigoryan E., Vu S., Allen C.D., Crawford E., Mandyam C.D., Koob G.F. Recruitment of medial prefrontal cortex neurons during alcohol withdrawal predicts cognitive impairment and excessive alcohol drinking. Proc. Natl. Acad. Sci. USA 2012, 109:18156-18161.
56. Ghitza U.E., Gray S.M., Epstein D.H., Rice K.C., Shaham Y. The anxiogenic drug yohimbine reinstates palatable food seeking in a rat relapse model: a role of CRF(1) receptors. Neuropsychopharmacology 2006, 31:2188-2196.
57. Giardino W.J., Ryabinin A.E. CRF1 receptor signaling regulates food and fluid intake in the drinking-in-the-dark model of binge alcohol consumption. Alcohol. Clin. Exp. Res. 2013, 37:1161-1170.
58. Giardino W.J., Cocking D.L., Kaur S., Cunningham C.L., Ryabinin A.E. Urocortin-1 within the centrally-projecting Edinger-Westphal nucleus is critical for ethanol preference. PLoS ONE 2011, 6:e26997.
59. Gilpin N.W., Richardson H.N., Koob G.F. Effects of CRF1-receptor and opioid-receptor antagonists on dependence-induced increases in alcohol drinking by alcohol-preferring (P) rats. Alcohol. Clin. Exp. Res. 2008, 32:1535-1542.
60. Greenwell T.N., Funk C.K., Cottone P., Richardson H.N., Chen S.A., Rice K.C., Zorrilla E.P., Koob G.F. Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats. Addict. Biol. 2009, 14:130-143.
61. Grigoriadis D.E., Liu X.J., Vaughn J., Palmer S.F., True C.D., Vale W.W., Ling N., De Souza E.B. 125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors. Mol. Pharmacol. 1996, 50:679-686.
62. Gysling K. Relevance of both type-1 and type-2 corticotropin releasing factor receptors in stress-induced relapse to cocaine seeking behaviour. Biochem. Pharmacol. 2012, 83:1-5.
63. Hansson A.C., Cippitelli A., Sommer W.H., Fedeli A., Bjork K., Soverchia L., Terasmaa A., Massi M., Heilig M., Ciccocioppo R. Variation at the rat Crhr1 locus and sensitivity to relapse into alcohol seeking induced by environmental stress. Proc. Natl. Acad. Sci. USA 2006, 103:15236-15241.
64. Hansson A.C., Cippitelli A., Sommer W.H., Ciccocioppo R., Heilig M. Region-specific down-regulation of Crhr1 gene expression in alcohol-preferring msP rats following ad lib access to alcohol. Addict. Biol. 2007, 12:30-34.
65. Heilig M., Koob G.F. A key role for corticotropin-releasing factor in alcohol dependence. Trends Neurosci. 2007, 30:399-406.
66. Heilig M., Egli M., Crabbe J.C., Becker H.C. Acute withdrawal, protracted abstinence and negative affect in alcoholism: are they linked?. Addict. Biol. 2010, 15:169-184.
67. Heilig M., Thorsell A., Sommer W.H., Hansson A.C., Ramchandani V.A., George D.T., Hommer D., Barr C.S. Translating the neuroscience of alcoholism into clinical treatments: from blocking the buzz to curing the blues. Neurosci. Biobehav. Rev. 2010, 35:334-344.
68. Heilig M., Goldman D., Berrettini W., O'brien C.P. Pharmacogenetic approaches to the treatment of alcohol addiction. Nat. Rev. Neurosci. 2011, 12:670-684.
69. Hershon H.I. Alcohol withdrawal symptoms and drinking behavior. J. Stud. Alcohol 1977, 38:953-971.
70. Ho S.P., Takahashi L.K., Livanov V., Spencer K., Lesher T., Maciag C., Smith M.A., Rohrbach K.W., Hartig P.R., Arneric S.P. Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor. Brain Res. Mol. Brain Res. 2001, 89:29-40.
71. Holsboer F., Ising M. Central CRH system in depression and anxiety - evidence from clinical studies with CRH1 receptor antagonists. Eur. J. Pharmacol. 2008, 583:350-357.
72. Hwa L.S., Debold J.F., Miczek K.A. Alcohol in excess: CRF(1) receptors in the rat and mouse VTA and DRN. Psychopharmacology (Berlin) 2013, 225:313-327.
73. Ingallinesi M., Rouibi K., Le Moine C., Papaleo F., Contarino A. CRF2 receptor-deficiency eliminates opiate withdrawal distress without impairing stress coping. Mol. Psychiatry 2012, 17:1283-1294.
74. Inoue K., Valdez G.R., Reyes T.M., Reinhardt L.E., Tabarin A., Rivier J., Vale W.W., Sawchenko P.E., Koob G.F., Zorrilla E.P. Human urocortin II, a selective agonist for the type 2 corticotropin-releasing factor receptor, decreases feeding and drinking in the rat. J. Pharmacol. Exp. Ther. 2003, 305:385-393.
75. Kaur S., Ryabinin A.E. Ghrelin receptor antagonism decreases alcohol consumption and activation of perioculomotor urocortin-containing neurons. Alcohol. Clin. Exp. Res. 2010, 34:1525-1534.
76. Kaur S., Li J., Stenzel-Poore M.P., Ryabinin A.E. Corticotropin-releasing factor acting on corticotropin-releasing factor receptor type 1 is critical for binge alcohol drinking in mice. Alcohol. Clin. Exp. Res. 2012, 36:369-376.
77. Kiianmaa K., Hyytia P., Samson H.H., Engel J.A., Svensson L., Soderpalm B., Larsson A., Colombo G., Vacca G., Finn D.A., Bachtell R.K., Ryabinin A.E. New neuronal networks involved in ethanol reinforcement. Alcohol. Clin. Exp. Res. 2003, 27:209-219.
78. Knapp D.J., Overstreet D.H., Moy S.S., Breese G.R. SB242084, flumazenil, and CRA1000 block ethanol withdrawal-induced anxiety in rats. Alcohol 2004, 32:101-111.
79. Knapp D.J., Overstreet D.H., Huang M., Wills T.A., Whitman B.A., Angel R.A., Sinnett S.E., Breese G.R. Effects of a stressor and corticotrophin releasing factor on ethanol deprivation-induced ethanol intake and anxiety-like behavior in alcohol-preferring P rats. Psychopharmacology (Berlin) 2011, 218:179-189.
80. Koob G.F. A role for brain stress systems in addiction. Neuron 2008, 59:11-34.
81. Koob G.F., Bloom F.E. Cellular and molecular mechanisms of drug dependence. Science 1988, 242:715-723.
82. Koob G.F., Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 2001, 24:97-129.
83. Koob G.F., Zorrilla E.P. Neurobiological mechanisms of addiction: focus on corticotropin-releasing factor. Curr. Opin. Investig. Drugs 2010, 11:63-71.
84. Koob G.F., Zorrilla E.P. Update on corticotropin-releasing factor pharmacotherapy for psychiatric disorders: a revisionist view. Neuropsychopharmacology 2012, 37:308-309.
85. Korosi A., Schotanus S., Olivier B., Roubos E.W., Kozicz T. Chronic ether stress-induced response of urocortin 1 neurons in the Edinger-Westphal nucleus in the mouse. Brain Res. 2005, 1046:172-179.
86. Kozicz T., Yanaihara H., Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J. Comp. Neurol. 1998, 391:1-10.
87. Kupferschmidt D.A., Lovejoy D.A., Rotzinger S., Erb S. Teneurin C-terminal associated peptide-1 blocks the effects of corticotropin-releasing factor on reinstatement of cocaine seeking and on cocaine-induced behavioural sensitization. Brit. J. Pharmacol. 2011, 162:574-583.
88. Kupferschmidt D.A., Klas P.G., Erb S. Cannabinoid CB1 receptors mediate the effects of corticotropin-releasing factor on the reinstatement of cocaine seeking and expression of cocaine-induced behavioural sensitization. Brit. J. Pharmacol. 2012, 167:196-206.
89. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., Shaham Y. The role of corticotrophin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology (Berlin) 2000, 150:317-324.
90. Le A.D., Harding S., Juzytsch W., Watchus J., Shalev U., Shaham Y. The role of corticotropin-releasing factor in stress-induced relapse to alcohol-seeking behavior in rats. Psychopharmacology 2000, 150:317-324.
91. Le A.D., Harding S., Juzytsch W., Fletcher P.J., Shaham Y. The role of corticotropin-releasing factor in the median raphe in relapse to alcohol seeking in rats. J. Neurosci. 2002, 22:7844-7849.
92. Le A.D., Funk D., Coen K., Li Z., Shaham Y. Role of corticotropin-releasing factor in the median raphe nucleus in yohimbine-induced reinstatement of alcohol seeking in rats. Addict. Biol. 2013, 18:448-451.
93. Lee B., Tiefenbacher S., Platt D.M., Spealman R.D. Pharmacological blockade of alpha(2)-arenoceptors induces reinstatement of cocaine-seeking behavior in squirrel monkeys. Neuropsychopharmacology 2004, 29:686-693.
94. Liu X., Weiss F. Additive effect of stress and drug cues on reinstatement of ethanol seeking: exacerbation by history of dependence and role of concurrent activation of corticotropin-releasing factor and opioid mechanisms. J. Neurosci. 2002, 22:7856-7861.
95. Lodge D.J., Lawrence A.J. The CRF1 receptor antagonist antalarmin reduces volitional ethanol consumption in isolation-reared fawn-hooded rats. Neuroscience 2003, 117:243-247.
96. Logrip M.L., Koob G.F., Zorrilla E.P. Role of corticotropin-releasing factor in drug addiction: potential for pharmacological intervention. CNS Drugs 2011, 25:271-287.
97. Logrip M.L., Zorrilla E.P., Koob G.F. Stress modulation of drug self-administration: implications for addiction comorbidity with post-traumatic stress disorder. Neuropharmacology 2012, 62:552-564.
98. Lowery E.G., Spanos M., Navarro M., Lyons A.M., Hodge C.W., Thiele T.E. CRF-1 antagonist and CRF-2 agonist decrease binge-like ethanol drinking in C57BL/6J mice independent of the HPA axis. Neuropsychopharmacology 2010, 35:1241-1252.
99. Lowery-Gionta E.G., Navarro M., Li C., Pleil K.E., Rinker J.A., Cox B.R., Sprow G.M., Kash T.L., Thiele T.E. Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL/6J mice. J. Neurosci. 2012, 32:3405-3413.
100. Lowman C., Allen J., Stout R.L. Replication and extension of Marlatt's taxonomy of relapse precipitants: overview of procedures and results. The Relapse Research Group. Addiction 1996, 91(Suppl.). S51-71.
101. Lu L., Shepard J.D., Hall F.S., Shaham Y. Effect of environmental stressors on opiate and psychostimulant reinforcement, reinstatement and discrimination in rats: a review. Neurosci. Biobehav. Rev. 2003, 27:457-491.
102. Marinelli P.W., Funk D., Juzytsch W., Harding S., Rice K.C., Shaham Y., Le A.D. The CRF(1) receptor antagonist antalarmin attenuates yohimbine-induced increases in operant alcohol self-administration and reinstatement of alcohol seeking in rats. Psychopharmacology 2007, 195:345-355.
103. Merlo Pich E., Lorang M., Yeganeh M., Rodriguez De Fonseca F., Raber J., Koob G.F., Weiss F. Increase of extracellular corticotropin-releasing factor-like immunoreactivity levels in the amygdala of awake rats during restraint stress and ethanol withdrawal as measured by microdialysis. J. Neurosci. 1995, 15:5439-5447.
104. Molander A., Vengeliene V., Heilig M., Wurst W., Deussing J.M., Spanagel R. Brain-specific inactivation of the Crhr1 gene inhibits post-dependent and stress-induced alcohol intake, but does not affect relapse-like drinking. Neuropsychopharmacology 2012, 37:1047-1056.
105. Mossberg D., Liljeberg P., Borg S. Clinical conditions in alcoholics during long-term abstinence: a descriptive, longitudinal treatment study. Alcohol 1985, 2:551-553.
106. Nawata Y., Kitaichi K., Yamamoto T. Increases of CRF in the amygdala are responsible for reinstatement of methamphetamine-seeking behavior induced by footshock. Pharmacol. Biochem. Behav. 2012, 101:297-302.
107. Nelson E.C., Agrawal A., Pergadia M.L., Wang J.C., Whitfield J.B., Saccone F.S., Kern J., Grant J.D., Schrage A.J., Rice J.P., Montgomery G.W., Heath A.C., Goate A.M., Martin N.G., Madden P.A. H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence. Addict. Biol. 2010, 15:1-11.
108. Olive M.F., Koenig H.N., Nannini M.A., Hodge C.W. Elevated extracellular CRF levels in the bed nucleus of the stria terminalis during ethanol withdrawal and reduction by subsequent ethanol intake. Pharmacol. Biochem. Behav. 2002, 72:213-220.
109. Overstreet D.H., Knapp D.J., Breese G.R. Accentuated decrease in social interaction in rats subjected to repeated ethanol withdrawals. Alcohol. Clin. Exp. Res. 2002, 26:1259-1268.
110. Overstreet D.H., Knapp D.J., Breese G.R. Modulation of multiple ethanol withdrawal-induced anxiety-like behavior by CRF and CRF1 receptors. Pharmacol. Biochem. Behav. 2004, 77:405-413.
111. Papaleo F., Kitchener P., Contarino A. Disruption of the CRF/CRF1 receptor stress system exacerbates the somatic signs of opiate withdrawal. Neuron 2007, 53:577-589.
112. Papaleo F., Ghozland S., Ingallinesi M., Roberts A.J., Koob G.F., Contarino A. Disruption of the CRF(2) receptor pathway decreases the somatic expression of opiate withdrawal. Neuropsychopharmacology 2008, 33:2878-2887.
113. Park P.E., Vendruscolo L.F., Schlosburg J.E., Edwards S., Schulteis G., Koob G.F. Corticotropin-releasing factor (CRF) and alpha 2 adrenergic receptors mediate heroin withdrawal-potentiated startle in rats. Int. J. Neuropsychopharmacol. 2013, 1-9.
114. Parylak S.L., Koob G.F., Zorrilla E.P. The dark side of food addiction. Physiol. Behav. 2011, 104:149-156.
115. Pastor R., Reed C., Burkhart-Kasch S., Li N., Sharpe A.L., Coste S.C., Stenzel-Poore M.P., Phillips T.J. Ethanol concentration-dependent effects and the role of stress on ethanol drinking in corticotropin-releasing factor type 1 and double type 1 and 2 receptor knockout mice. Psychopharmacology (Berlin) 2011, 218:169-177.
116. Pickens R.W., Hatsukami D.K., Spicer J.W., Svikis D.S. Relapse by alcohol abusers. Alcohol. Clin. Exp. Res. 1985, 9:244-247.
117. Plaza-Zabala A., Martin-Garcia E., De Lecea L., Maldonado R., Berrendero F. Hypocretins regulate the anxiogenic-like effects of nicotine and induce reinstatement of nicotine-seeking behavior. J. Neurosci. 2010, 30:2300-2310.
118. Pohorecky L.A. Stress and alcohol interaction: an update of human research. Alcohol. Clin. Exp. Res. 1991, 15:438-459.
119. Potter E., Behan D.P., Fischer W.H., Linton E.A., Lowry P.J., Vale W.W. Cloning and characterization of the cDNAs for human and rat corticotropin releasing factor-binding proteins. Nature 1991, 349:423-426.
120. Potter E., Behan D.P., Linton E.A., Lowry P.J., Sawchenko P.E., Vale W.W. The central distribution of a corticotropin-releasing factor (CRF)-binding protein predicts multiple sites and modes of interaction with CRF. Proc. Natl. Acad. Sci. USA 1992, 89:4192-4196.
121. Primus R.J., Yevich E., Baltazar C., Gallager D.W. Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain. Neuropsychopharmacology 1997, 17:308-316.
122. Ray L.A. Stress-induced and cue-induced craving for alcohol in heavy drinkers: preliminary evidence of genetic moderation by the OPRM1 and CRH-BP genes. Alcohol. Clin. Exp. Res. 2011, 35:166-174.
123. Rehm J., Mathers C., Popova S., Thavorncharoensap M., Teerawattananon Y., Patra J. Global burden of disease and injury and economic cost attributable to alcohol use and alcohol-use disorders. Lancet 2009, 373:2223-2233.
124. Ribbe K., Ackermann V., Schwitulla J., Begemann M., Papiol S., Grube S., Sperling S., Friedrichs H., Jahn O., Sillaber I., Gefeller O., Krampe H., Ehrenreich H. Prediction of the risk of comorbid alcoholism in schizophrenia by interaction of common genetic variants in the corticotropin-releasing factor system. Arch. Gen. Psychiatry 2011, 68:1247-1256.
125. Richardson H.N., Zhao Y., Fekete E.M., Funk C.K., Wirsching P., Janda K.D., Zorrilla E.P., Koob G.F. MPZP: a novel small molecule corticotropin-releasing factor type 1 receptor (CRF1) antagonist. Pharmacol. Biochem. Behav. 2008, 88:497-510.
126. Richter R.M., Weiss F. In vivo CRF release in rat amygdala is increased during cocaine withdrawal in self-administering rats. Synapse 1999, 32:254-261.
127. Rimondini R., Arlinde C., Sommer W., Heilig M. Long-lasting increase in voluntary ethanol consumption and transcriptional regulation in the rat brain after intermittent exposure to alcohol. FASEB J. 2002, 16:27-35.
128. Roberto M., Cruz M.T., Gilpin N.W., Sabino V., Schweitzer P., Bajo M., Cottone P., Madamba S.G., Stouffer D.G., Zorrilla E.P., Koob G.F., Siggins G.R., Parsons L.H. Corticotropin releasing factor-induced amygdala gamma-aminobutyric acid release plays a key role in alcohol dependence. Biol. Psychiatry 2010, 67:831-839.
129. Rodriguez De Fonseca F., Carrera M.R., Navarro M., Koob G.F., Weiss F. Activation of corticotropin-releasing factor in the limbic system during cannabinoid withdrawal. Science 1997, 276:2050-2054.
130. Ryabinin A.E., Weitemier A.Z. The urocortin 1 neurocircuit: ethanol-sensitivity and potential involvement in alcohol consumption. Brain Res. Rev. 2006, 52:368-380.
131. Ryabinin A.E., Bachtell R.K., Freeman P., Risinger F.O. ITF expression in mouse brain during acquisition of alcohol self-administration. Brain Res. 2001, 890:192-195.
132. Ryabinin A.E., Galvan-Rosas A., Bachtell R.K., Risinger F.O. High alcohol/sucrose consumption during dark circadian phase in C57BL/6J mice: involvement of hippocampus, lateral septum and urocortin-positive cells of the Edinger-Westphal nucleus. Psychopharmacology (Berlin) 2003, 165:296-305.
133. Ryabinin A.E., Tsivkovskaia N.O., Ryabinin S.A. Urocortin 1-containing neurons in the human Edinger-Westphal nucleus. Neuroscience 2005, 134:1317-1323.
134. Ryabinin A.E., Yoneyama N., Tanchuck M.A., Mark G.P., Finn D.A. Urocortin 1 microinjection into the mouse lateral septum regulates the acquisition and expression of alcohol consumption. Neuroscience 2008, 151:780-790.
135. Sabino V., Cottone P., Koob G.F., Steardo L., Lee M.J., Rice K.C., Zorrilla E.P. Dissociation between opioid and CRF1 antagonist sensitive drinking in Sardinian alcohol-preferring rats. Psychopharmacology (Berlin) 2006, 189:175-186.
136. Sanchez M.M., Young L.J., Plotsky P.M., Insel T.R. Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain. J. Comp. Neurol. 1999, 408:365-377.
137. Sarnyai Z., Biro E., Gardi J., Vecsernyes M., Julesz J., Telegdy G. Brain corticotropin-releasing factor mediates 'anxiety-like' behavior induced by cocaine withdrawal in rats. Brain Res. 1995, 675:89-97.
138. Schmid B., Blomeyer D., Treutlein J., Zimmermann U.S., Buchmann A.F., Schmidt M.H., Esser G., Rietschel M., Banaschewski T., Schumann G., Laucht M. Interacting effects of CRHR1 gene and stressful life events on drinking initiation and progression among 19-year-olds. Int. J. Neuropsychopharmacol. 2010, 13:703-714.
139. Shaham Y., Funk D., Erb S., Brown T.J., Walker C.D., Stewart J. Corticotropin-releasing factor, but not corticosterone, is involved in stress-induced relapse to heroin-seeking in rats. J. Neurosci. 1997, 17:2605-2614.
140. Shaham Y., Erb S., Leung S., Buczek Y., Stewart J. CP-154,526, a selective, non-peptide antagonist of the corticotropin-releasing factor1 receptor attenuates stress-induced relapse to drug seeking in cocaine- and heroin-trained rats. Psychopharmacology (Berlin) 1998, 137:184-190.
141. Shaham Y., Shalev U., Lu L., De Wit H., Stewart J. The reinstatement model of drug relapse: history, methodology and major findings. Psychopharmacology (Berlin) 2003, 168:3-20.
142. Shalev U., Erb S., Shaham Y. Role of CRF and other neuropeptides in stress-induced reinstatement of drug seeking. Brain Res. 2010, 1314:15-28.
143. Sharpe A.L., Phillips T.J. Central urocortin 3 administration decreases limited-access ethanol intake in nondependent mice. Behav. Pharmacol. 2009, 20:346-351.
144. Sharpe A.L., Tsivkovskaia N.O., Ryabinin A.E. Ataxia and c-Fos expression in mice drinking ethanol in a limited access session. Alcohol. Clin. Exp. Res. 2005, 29:1419-1426.
145. Shepard J.D., Bossert J.M., Liu S.Y., Shaham Y. The anxiogenic drug yohimbine reinstates methamphetamine seeking in a rat model of drug relapse. Biol. Psychiatry 2004, 55:1082-1089.
146. Simms J.A., Steensland P., Medina B., Abernathy K.E., Chandler L.J., Wise R., Bartlett S.E. Intermittent access to 20% ethanol induces high ethanol consumption in Long-Evans and Wistar rats. Alcohol. Clin. Exp. Res. 2008, 32:1816-1823.
147. Simms, J.A., Nielsen, C.K., Li, R., Bartlett, S.E., 2013. Intermittent access ethanol consumption dysregulates CRF function in the hypothalamus and is attenuated by the CRF-R1 antagonist, CP-376395. Addict. Biol.
148. Sinha R. New findings on biological factors predicting addiction relapse vulnerability. Curr. Psychiatry Rep. 2011, 13:398-405.
149. Sinha R., Fuse T., Aubin L.R., O'malley S.S. Psychological stress, drug-related cues and cocaine craving. Psychopharmacology (Berlin) 2000, 152:140-148.
150. Skelton K.H., Gutman D.A., Thrivikraman K.V., Nemeroff C.B., Owens M.J. The CRF1 receptor antagonist R121919 attenuates the neuroendocrine and behavioral effects of precipitated lorazepam withdrawal. Psychopharmacology (Berlin) 2007, 192:385-396.
151. Solomon R.L., Corbit J.D. An opponent-process theory of motivation. I. Temporal dynamics of affect. Psychol. Rev. 1974, 81:119-145.
152. Sommer W.H., Rimondini R., Hansson A.C., Hipskind P.A., Gehlert D.R., Barr C.S., Heilig M.A. Upregulation of voluntary alcohol intake, behavioral sensitivity to stress, and amygdala crhr1 expression following a history of dependence. Biol. Psychiatry 2008, 63:139-145.
153. Spangler E., Cote D.M., Anacker A.M., Mark G.P., Ryabinin A.E. Differential sensitivity of the perioculomotor urocortin-containing neurons to ethanol, psychostimulants and stress in mice and rats. Neuroscience 2009, 160:115-125.
154. Specio S.E., Wee S., O'dell L.E., Boutrel B., Zorrilla E.P., Koob G.F. CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats. Psychopharmacology (Berlin) 2008, 196:473-482.
155. Spina M., Merlo-Pich E., Chan R.K., Basso A.M., Rivier J., Vale W., Koob G.F. Appetite-suppressing effects of urocortin, a CRF-related neuropeptide. Science 1996, 273:1561-1564.
156. Steketee J.D., Kalivas P.W. Drug wanting: behavioral sensitization and relapse to drug-seeking behavior. Pharmacol. Rev. 2011, 63:348-365.
157. Stine S.M., Southwick S.M., Petrakis I.L., Kosten T.R., Charney D.S., Krystal J.H. Yohimbine-induced withdrawal and anxiety symptoms in opioid-dependent patients. Biol. Psychiatry 2002, 51:642-651.
158. Stinus L., Cador M., Zorrilla E.P., Koob G.F. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats. Neuropsychopharmacology 2005, 30:90-98.
159. Sutton R.E., Koob G.F., Le Moal M., Rivier J., Vale W. Corticotropin releasing factor produces behavioural activation in rats. Nature 1982, 297:331-333.
160. Swanson L.W., Sawchenko P.E., Rivier J., Vale W.W. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study. Neuroendocrinology 1983, 36:165-186.
161. Takahashi L.K., Ho S.P., Livanov V., Graciani N., Arneric S.P. Antagonism of CRF(2) receptors produces anxiolytic behavior in animal models of anxiety. Brain Res. 2001, 902:135-142.
162. Tartter M.A., Ray L.A. A prospective study of stress and alcohol craving in heavy drinkers. Pharmacol. Biochem. Behav. 2012, 101:625-631.
163. Teegarden S.L., Scott A.N., Bale T.L. Early life exposure to a high fat diet promotes long-term changes in dietary preferences and central reward signaling. Neuroscience 2009, 162:924-932.
164. Topple A.N., Hunt G.E., Mcgregor I.S. Possible neural substrates of beer-craving in rats. Neurosci. Lett. 1998, 252:99-102.
165. Torres O.V., Gentil L.G., Natividad L.A., Carcoba L.M., O'dell L.E. Behavioral, biochemical, and molecular indices of stress are enhanced in female versus male rats experiencing nicotine withdrawal. Front. Psychiatry 2013, 4:38.
166. Treutlein J., Kissling C., Frank J., Wiemann S., Dong L., Depner M., Saam C., Lascorz J., Soyka M., Preuss U.W., Rujescu D., Skowronek M.H., Rietschel M., Spanagel R., Heinz A., Laucht M., Mann K., Schumann G. Genetic association of the human corticotropin releasing hormone receptor 1 (CRHR1) with binge drinking and alcohol intake patterns in two independent samples. Mol. Psychiatry 2006, 11:594-602.
167. Tucci S., Cheeta S., Seth P., File S.E. Corticotropin releasing factor antagonist, alpha-helical CRF(9-41), reverses nicotine-induced conditioned, but not unconditioned, anxiety. Psychopharmacology (Berlin) 2003, 167:251-256.
168. Turek V.F., Ryabinin A.E. Expression of c-Fos in the mouse Edinger-Westphal nucleus following ethanol administration is not secondary to hypothermia or stress. Brain Res. 2005, 1063:132-139.
169. Turek V.F., Bennett B., Ryabinin A.E. Differences in the urocortin 1 system between long-sleep and short-sleep mice. Genes Brain Behav. 2008, 7:113-119.
170. Umhau J.C., Schwandt M.L., Usala J., Geyer C., Singley E., George T.D., Heilig M. Pharmacologically induced alcohol craving in treatment seeking alcoholics correlates with alcoholism severity, but is insensitive to acamprosate. Neuropsychopharmacology 2011, 60:303-311.
171. Valdez G.R., Inoue K., Koob G.F., Rivier J., Vale W., Zorrilla E.P. Human urocortin II: mild locomotor suppressive and delayed anxiolytic-like effects of a novel corticotropin-releasing factor related peptide. Brain Res. 2002, 943:142-150.
172. Valdez G.R., Roberts A.J., Chan K., Davis H., Brennan M., Zorrilla E.P., Koob G.F. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor. Alcohol. Clin. Exp. Res. 2002, 26:1494-1501.
173. Valdez G.R., Zorrilla E.P., Rivier J., Vale W.W., Koob G.F. Locomotor suppressive and anxiolytic-like effects of urocortin 3, a highly selective type 2 corticotropin-releasing factor agonist. Brain Res. 2003, 980:206-212.
174. Valdez G.R., Zorrilla E.P., Roberts A.J., Koob G.F. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence. Alcohol 2003, 29:55-60.
175. Valdez G.R., Sabino V., Koob G.F. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation. Alcohol. Clin. Exp. Res. 2004, 28:865-872.
176. Vale W., Spiess J., Rivier C., Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981, 213:1394-1397.
177. Van Pett K., Viau V., Bittencourt J.C., Chan R.K., Li H.Y., Arias C., Prins G.S., Perrin M., Vale W., Sawchenko P.E. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J. Comp. Neurol. 2000, 428:191-212.
178. Vaughan J., Donaldson C., Bittencourt J., Perrin M.H., Lewis K., Sutton S., Chan R., Turnbull A.V., Lovejoy D., Rivier C., et al. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995, 378:287-292.
179. Vendruscolo L.F., Barbier E., Schlosburg J.E., Misra K.K., Whitfield T.W., Logrip M.L., Rivier C., Repunte-Canonigo V., Zorrilla E.P., Sanna P.P., Heilig M., Koob G.F. Corticosteroid-dependent plasticity mediates compulsive alcohol drinking in rats. J. Neurosci. 2012, 32:7563-7571.
180. Wang B., Shaham Y., Zitzman D., Azari S., Wise R.A., You Z.B. Cocaine experience establishes control of midbrain glutamate and dopamine by corticotropin-releasing factor: a role in stress-induced relapse to drug seeking. J. Neurosci. 2005, 25:5389-5396.
181. Wang J., Fang Q., Liu Z., Lu L. Region-specific effects of brain corticotropin-releasing factor receptor type 1 blockade on footshock-stress- or drug-priming-induced reinstatement of morphine conditioned place preference in rats. Psychopharmacology 2006, 185:19-28.
182. Wang B., You Z.B., Rice K.C., Wise R.A. Stress-induced relapse to cocaine seeking: roles for the CRF(2) receptor and CRF-binding protein in the ventral tegmental area of the rat. Psychopharmacology (Berlin) 2007, 193:283-294.
183. Weiss F., Ciccocioppo R., Parsons L.H., Katner S., Liu X., Zorrilla E.P., Valdez G.R., Ben-Shahar O., Angeletti S., Richter R.R. Compulsive drug-seeking behavior and relapse. Neuroadaptation, stress, and conditioning factors. Ann. N. Y. Acad. Sci. 2001, 937:1-26.
184. Weitemier A.Z., Ryabinin A.E. Lesions of the Edinger-Westphal nucleus alter food and water consumption. Behav. Neurosci. 2005, 119:1235-1243.
185. Weitemier A.Z., Woerner A., Backstrom P., Hyytia P., Ryabinin A.E. Expression of c-Fos in Alko alcohol rats responding for ethanol in an operant paradigm. Alcohol. Clin. Exp. Res. 2001, 25:704-710.
186. Weitemier A.Z., Tsivkovskaia N.O., Ryabinin A.E. Urocortin 1 distribution in mouse brain is strain-dependent. Neuroscience 2005, 132:729-740.
187. Wills T.A., Knapp D.J., Overstreet D.H., Breese G.R. Interactions of stress and CRF in ethanol-withdrawal induced anxiety in adolescent and adult rats. Alcohol. Clin. Exp. Res. 2010, 34:1603-1612.
188. Wise R.A. Voluntary ethanol intake in rats following exposure to ethanol on various schedules. Psychopharmacologia 1973, 29:203-210.
189. Zhao Y., Valdez G.R., Fekete E.M., Rivier J.E., Vale W.W., Rice K.C., Weiss F., Zorrilla E.P. Subtype-selective corticotropin-releasing factor receptor agonists exert contrasting, but not opposite, effects on anxiety-related behavior in rats. J. Pharmacol. Exp. Ther. 2007, 323:846-854.
190. Zhao Y., Weiss F., Zorrilla E.P. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats. Alcohol. Clin. Exp. Res. 2007, 31:1505-1515.
191. Zislis G., Desai T.V., Prado M., Shah H.P., Bruijnzeel A.W. Effects of the CRF receptor antagonist D-Phe CRF(12-41) and the alpha2-adrenergic receptor agonist clonidine on stress-induced reinstatement of nicotine-seeking behavior in rats. Neuropharmacology 2007, 53:958-966.
192. Zorrilla E.P., Koob G.F. The therapeutic potential of CRF1 antagonists for anxiety. Expert Opin. Investig. Drugs 2004, 13:799-828.
193. Zorrilla E.P., Koob G.F. Progress in corticotropin-releasing factor-1 antagonist development. Drug Discov. Today 2010, 15:371-383.
194. Zorrilla E.P., Valdez G.R., Weiss F. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats. Psychopharmacology (Berlin) 2001, 158:374-381.
195. Zorrilla E.P., Wee S., Zhao Y., Specio S., Boutrel B., Koob G.F., Weiss F. Extended access cocaine self-administration differentially activates dorsal raphe and amygdala corticotropin-releasing factor systems in rats. Addict. Biol. 2012, 17:300-308.
196. Zorrilla E.P., Heilig M., De Wit H., Shaham Y. Behavioral, biological, and chemical perspectives on targeting CRF(1) receptor antagonists to treat alcoholism. Drug Alcohol Depend. 2013, 128:175-186.
197. Zorrilla E.P., Roberts A.J., Rivier J.E., Koob G.F. Anxiolytic-like effects of antisauvagine-30 in mice are not mediated by CRF2 receptors. PLoS ONE 2013, 8:e63942.
198. Zywiak W.H., Connors G.J., Maisto S.A., Westerberg V.S. Relapse research and the Reasons for Drinking Questionnaire: a factor analysis of Marlatt's relapse taxonomy. Addiction 1996, 91(Suppl.). S121-130.